KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Other Non Operating Income (2016 - 2023)

TherapeuticsMD's Other Non Operating Income history spans 12 years, with the latest figure at $359000.0 for Q3 2023.

  • For Q3 2023, Other Non Operating Income rose 420.54% year-over-year to $359000.0; the TTM value through Sep 2023 reached $880000.0, up 110.33%, while the annual FY2022 figure was -$117000.0, 143.01% down from the prior year.
  • Other Non Operating Income reached $359000.0 in Q3 2023 per TXMD's latest filing, up from $103000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $703662.0 in Q3 2019 to a low of -$10.1 million in Q2 2019.
  • Average Other Non Operating Income over 5 years is -$782347.2, with a median of $103000.0 recorded in 2023.
  • Peak YoY movement for Other Non Operating Income: tumbled 6985.25% in 2022, then surged 743.75% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $621020.0 in 2019, then crashed by 78.74% to $132000.0 in 2020, then tumbled by 93.94% to $8000.0 in 2021, then soared by 37.5% to $11000.0 in 2022, then skyrocketed by 3163.64% to $359000.0 in 2023.
  • Per Business Quant, the three most recent readings for TXMD's Other Non Operating Income are $359000.0 (Q3 2023), $103000.0 (Q2 2023), and $407000.0 (Q1 2023).